Phase 1 IBD Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Phase 1 Study of PVT401 in Healthy Subjects

Inflammatory Bowel Disease (IBD)

Parvus Therapeutics, Inc.36 enrolled1 locationNCT07423000

Recruiting

Phase 1

A Phase I Study of HW201877 in Healthy Subjects

Healthy ParticipantsIBD (Inflammatory Bowel Disease)

Wuhan Humanwell Innovative Drug Research and Development Center Limited Company104 enrolled1 locationNCT07373457